Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Moultrie

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The Pediatric Infectious Disease Journal|July 21, 2015
Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level ReferencesOlivia Keiser, Nello Blaser, Mary-Ann Davies, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIFLesley Erica Scott, Anne Nicole Shapiro, Manuel Pedro Da Silva, et al.
AIDS (London, England)|November 14, 2014
Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling studyLuisa Salazar-Vizcaya, Olivia Keiser, Karl Technau, et al.
Scientific Reports|November 27, 2023
Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigationAnne N Shapiro, Lesley Scott, Harry Moultrie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 16, 2010
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaborationMorna Cornell, Karl Technau, Lara Fairall, et al.
Pediatrics|September 19, 2012
Variability of growth in children starting antiretroviral treatment in southern AfricaThomas Gsponer, Ralf Weigel, Mary-Ann Davies, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsMary-Ann Davies, Margaret May, Carolyn Bolton-Moore, et al.
Plos One|December 24, 2013
Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA CollaborationMary-Ann Davies, Sam Phiri, Robin Wood, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern AfricaLukas Fenner, Martin W G Brinkhof, Olivia Keiser, et al.
Plos Medicine|November 22, 2013
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaMichael Schomaker, Matthias Egger, James Ndirangu, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The Pediatric Infectious Disease Journal|July 21, 2015
Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level ReferencesOlivia Keiser, Nello Blaser, Mary-Ann Davies, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIFLesley Erica Scott, Anne Nicole Shapiro, Manuel Pedro Da Silva, et al.
AIDS (London, England)|November 14, 2014
Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling studyLuisa Salazar-Vizcaya, Olivia Keiser, Karl Technau, et al.
Scientific Reports|November 27, 2023
Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigationAnne N Shapiro, Lesley Scott, Harry Moultrie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 16, 2010
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaborationMorna Cornell, Karl Technau, Lara Fairall, et al.
Pediatrics|September 19, 2012
Variability of growth in children starting antiretroviral treatment in southern AfricaThomas Gsponer, Ralf Weigel, Mary-Ann Davies, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsMary-Ann Davies, Margaret May, Carolyn Bolton-Moore, et al.
Plos One|December 24, 2013
Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA CollaborationMary-Ann Davies, Sam Phiri, Robin Wood, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern AfricaLukas Fenner, Martin W G Brinkhof, Olivia Keiser, et al.
Plos Medicine|November 22, 2013
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaMichael Schomaker, Matthias Egger, James Ndirangu, et al.
Pageof 7